RANDOMIZED PHASE III TRIAL COMPARING GAMMA KNIFE (GK) AND LINAC BASED (EDGE) RADIOSURGERY FOR BRAIN METASTASES FROM SOLID TUMORS: RESULTS FROM THE GADGET TRIAL

被引：0
|
作者：
Clerici, E. [1 ]
Navarria, P. [1 ]
Franzese, C. [1 ]
Carta, G. A. [1 ]
Mancosu, P. [1 ]
Reggiori, G. [1 ]
Picozzi, P. [1 ]
Attuati, L. [1 ]
Tomatis, S. [1 ]
Scorsetti, M. [1 ,2 ]
机构：
[1] Humanitas Canc Ctr & Res Hosp, Rozzano, MI, Italy
[2] Humanitas Univ, Milan, Italy
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS6.5
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [21] PLAN QUALITY OF STEREOTACTIC RADIOSURGERY IN A MULTICENTER PHASE III RANDOMIZED TRIAL IN PATIENTS WITH 4 UP TO 10 BRAIN METASTASES
    Hartgerink, D.
    Swinnen, A.
    Bruynzeel, A.
    Hurkmans, C.
    de Ruysscher, D.
    van der Toorn, P.
    Swaak, A.
    Wiggenraad, R.
    Veelen, L.
    Verhoeff, J.
    van der Geest, A.
    Dieleman, E.
    Jonkman, A.
    Wester, G.
    Zindler, J.
    NEURO-ONCOLOGY, 2018, 20 : 309 - 310
  • [22] Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): Early results from a multicenter phase I trial.
    McClelland, Shearwood
    Lautenschlaeger, Tim
    Shiue, Kevin
    Miller, Amy C.
    Zang, Yong
    Lauer, Kathryn I.
    Hanna, Nasser H.
    Rhome, Ryan
    Agrawal, Namita
    Anthony, Paul
    Shan, Mu
    Jaboin, Jerry Jeff
    Watson, Gordon A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] QUALITY OF LIFE RESULTS OF AN EORTC PHASE III RANDOMIZED TRIAL OF ADJUVANT WHOLE-BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES OF SOLID TUMORS
    Soffietti, Riccardo
    Mueller, Rolf P.
    Abacioglu, Ufuk
    Villa, Salvador
    Fauchon, Francois
    Baumert, Brigitta
    Fariselli, Laura
    Tridello, Gloria
    Kocher, Martin
    Bottomley, Andrew
    NEURO-ONCOLOGY, 2010, 12 : 101 - 101
  • [24] Quality-of-life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors
    Soffietti, R.
    Mueller, R. P.
    Abacioglu, M. U.
    Villa, S.
    Fauchon, F.
    Baumert, B.
    Fariselli, L.
    Tridello, G.
    Kocher, M.
    Bottomley, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
    Park, Se Hoon
    Lee, Jeeyun
    Sohn, Tae Sung
    Lim, Do Hoon
    Kim, Kyoung-Mee
    An, Ji Yeong
    Choi, Min Gew
    Lee, Jun Ho
    Bae, Jae Moon
    Kim, Sung
    Lee, Su Jin
    Kim, Seung Tae
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    PRECISION AND FUTURE MEDICINE, 2019, 3 (01): : 24 - 29
  • [26] A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases
    Das, Subhadip
    Faruqi, Salman
    Nordal, Robert
    Starreveld, Yves
    Kelly, John
    Bowden, Gregory
    Amanie, John
    Fairchild, Alysa
    Lim, Gerald
    Loewen, Shaun
    Rowe, Lindsay
    Wallace, Carla
    Ghosh, Sunita
    Patel, Samir
    BMC CANCER, 2022, 22 (01)
  • [27] A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases
    Subhadip Das
    Salman Faruqi
    Robert Nordal
    Yves Starreveld
    John Kelly
    Gregory Bowden
    John Amanie
    Alysa Fairchild
    Gerald Lim
    Shaun Loewen
    Lindsay Rowe
    Carla Wallace
    Sunita Ghosh
    Samir Patel
    BMC Cancer, 22
  • [28] Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Javier Cortés
    Hope S. Rugo
    Ahmad Awada
    Chris Twelves
    Edith A. Perez
    Seock–Ah Im
    Patricia Gómez-Pardo
    Lee S. Schwartzberg
    Veronique Diéras
    Denise A. Yardley
    David A. Potter
    Audrey Mailliez
    Alvaro Moreno-Aspitia
    Jin-Seok Ahn
    Carol Zhao
    Ute Hoch
    Mary Tagliaferri
    Alison L. Hannah
    Joyce O’Shaughnessy
    Breast Cancer Research and Treatment, 2017, 165 : 329 - 341
  • [29] Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Cortes, Javier
    Rugo, Hope S.
    Awada, Ahmad
    Twelves, Chris
    Perez, Edith A.
    Im, Seock-Ah
    Gomez-Pardo, Patricia
    Schwartzberg, Lee S.
    Dieras, Veronique
    Yardley, Denise A.
    Potter, David A.
    Mailliez, Audrey
    Moreno-Aspitia, Alvaro
    Ahn, Jin-Seok
    Zhao, Carol
    Hoch, Ute
    Tagliaferri, Mary
    Hannah, Alison L.
    O'Shaughnessy, Joyce
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (02) : 329 - 341
  • [30] Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial
    Huiping Li
    Yan Huang
    Zhendong Chen
    Aiping Zeng
    Helong Zhang
    Yan Yu
    Shihong Wei
    Qingshan Li
    Xiaojia Wang
    Xiangcai Wang
    Xiuwen Wang
    Runxiang Yang
    Xiumei Dai
    Minghong Bi
    Tao Sun
    Qingyuan Zhang
    Cuicui Han
    Yujie Li
    Xiaoyan Kang
    Yaxin Liu
    Li Zhang
    BioDrugs, 2023, 37 : 259 - 269
12345